National Institute of Mental Health (NIMH)
nimh.nih.govLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
363
Active
46
Phase 3
10
Total enrollment
149,379
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine Hydrochloride | — | — | — | — | — | 1 | |
| Fluoxetine | — | — | — | 4 | |||
| 18F-PF-06445974 | — | — | — | — | — | 3 | |
| 11C-PS13 | — | — | — | — | 3 | ||
| 18f-florbetaben | — | — | — | — | — | 2 | |
| 11C-MC1 | — | — | — | — | 3 | ||
| Ketamine | — | — | — | — | 2 | ||
| 11C-JMJ-129 | — | — | — | — | — | 1 | |
| 11C-ARMI | — | — | — | — | — | 1 | |
| Apremilast | — | — | — | — | — | 1 | |
| Arm 1, 2, 3 drug Interventions | — | — | — | — | — | 1 | |
| Arm 1 and 2 Interventions | — | — | — | — | — | 1 | |
| Intravenous Ethanol | — | — | — | — | — | 1 | |
| 11C-MCI | — | — | — | — | — | 1 | |
| 11CPS13 | — | — | — | — | — | 1 | |
| 18F-PF974 | — | — | — | — | — | 1 | |
| 11C-ZTP-1 | — | — | — | — | — | 1 | |
| Lithium | — | — | — | — | 3 |
Next readouts
- 2027-01-01
- 2027-02-01
- 2028-02-22
- 2028-02-22
- 2028-02-22
- 2028-10-03
- 2028-12-11
- 2029-01-01
- 2029-02-05
- 2029-03-19
Top conditions
- Healthy65
- Depression47
- Schizophrenia34
- Bipolar Disorder34
- Major Depressive Disorder18
- Mood Disorder16
- Anxiety Disorders14
- Healthy Volunteers13
Frequently asked questions about National Institute of Mental Health (NIMH)
- How many clinical trials does National Institute of Mental Health (NIMH) have on ClinicalTrials.gov?
- National Institute of Mental Health (NIMH) is listed as the lead sponsor on 363 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National Institute of Mental Health (NIMH)'s trials are in Phase 3?
- 10 of National Institute of Mental Health (NIMH)'s trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does National Institute of Mental Health (NIMH) focus on?
- National Institute of Mental Health (NIMH)'s most-studied conditions on ClinicalTrials.gov are Healthy, Depression, Schizophrenia, Bipolar Disorder, Major Depressive Disorder.
- When are National Institute of Mental Health (NIMH)'s next clinical trial readouts?
- National Institute of Mental Health (NIMH) has 10 upcoming primary-completion readouts tracked here; the soonest is “Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder”, expected around 2027-01-01.